Cuál es el precio por Anxo Pharmaceutical Co., Ltd. (6677)

Precio por Anxo Pharmaceutical Co., Ltd. (6677) es de$0.52786386

Cuál es la capitalización de mercado por Anxo Pharmaceutical Co., Ltd. (6677)

Capitalización de mercado por Anxo Pharmaceutical Co., Ltd. (6677) es $29.55M

Ganancias de Anxo Pharmaceutical Co., Ltd. (6677)

Anxo Pharmaceutical Co., Ltd. functions as a specialized enterprise in the pharmaceutical sector. This company is actively involved in the research, production, and global distribution of various medicinal products, catering to both healthcare professionals and individual patients, particularly within Taiwan and across international markets. Its comprehensive product catalog features both prescription-only drugs and over-the-counter remedies, addressing a broad spectrum of therapeutic needs. These include cardiovascular health, metabolic disorders, conditions affecting the central nervous system, diabetes management, respiratory ailments, anti-infective treatments, dermatological issues, nephrology, urology, and orthopedics, among others. More specifically, Anxo supplies agents for antidiabetic and dyslipidemic conditions, supports cardiovascular and circulatory systems, offers therapies for the nervous system, addresses hepatological and gastroenterological concerns, provides anti-infective and antiviral agents, and assists with hemodialysis and urinary system treatments. Additionally, their offerings cover respiratory system and antihistamine applications, various analgesics, and other specialized medications, including a range of injectable pharmaceuticals. Established in 2003, the company's main operational base is situated in Taipei, Taiwan.

Año	Ganancias	Cambiar
Not enough data for the provided dates.

Año

Ganancias

Cambiar

Not enough data for the provided dates.

Empresa	Ganancias	Diferencia de ganancias	País
MERCK Kommanditgesellschaft auf Aktien MER.SW	-	-	DE
Merck KGaA MRK.DE	-	-	DE
Takeda Pharmaceutical Company Limited 4502.T	-	-	JP
Galderma Group AG GALD.SW	-	-	CH
Sun Pharmaceutical Industries Limited SUNPHARMA.NS	$1.76B	-	IN

Empresa

Ganancias

Diferencia de ganancias

País